Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
14,675,770
-
Share change
-
+2,922,007
-
Total reported value
-
$4,839,651
-
Price per share
-
$0.33
-
Number of holders
-
30
-
Value change
-
+$962,491
-
Number of buys
-
17
-
Number of sells
-
3
Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q4 2024
As of 31 Dec 2024,
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,675,770 shares.
The largest 10 holders included
BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, JANE STREET GROUP, LLC, Point72 Asset Management, L.P., NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, PFG Investments, LLC, TWO SIGMA INVESTMENTS, LP, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.